Jazz Pharmaceuticals to acquire rare disease company Gentium
Authored by James Sheppard Jazz Pharmaceuticals, based in Dublin, Ireland, recently announced that it had acquired Italian based rare disease drug company Gentium in a $1bn deal. The deal will give...
View ArticleADC Therapeutics executives on fast track with funding and partners
Authored by James Sheppard ADC Therapeutics was launched in 2012 after Auven Therapeutics (previously known as Celtic Therapeutics) launched the company with initial funding of $50m. These funds were...
View ArticleRoche purchases diagnostic company IQuum
Authored by James Sheppard The global pharmaceutical giant Roche announced that it completed the purchase of Boston biotech cluster based, diagnostics company IQuum. IQuum specialise in the development...
View Article5 Alternative Methods for assessing the potential of a new employer
Authored by Karl Simpson Below are some ideas for the contrarians among you who might assess a new job opportunity. These escape the traditional clichés and provoke you to think about why you might...
View ArticleRoche announces acquisition of InterMune
Authored by James Sheppard The global pharmaceutical company Roche has announced it has purchased the California based, biotech, InterMune, for $8.3bn. The deal will give Roche access to a potential...
View ArticleM&A Continues to Dominate the Rare Diseases Landscape
Alexion took everyone by surprise in recent weeks by announcing a very sizable acquisition of Boston-based Synageva for $8.4bn. This was a significant deal which will only serve to strengthen...
View ArticleBiotech M&A Continues to Climb the Curve
The trajectory of biotech M&A has been steep in 2015, so the $7.2bn acquisition of Receptos by oncology powerhouse Celgene, increases the gradient even further. This deal came out of left field,...
View ArticleShire goes hostile on Baxter spin-out Baxalta
Fresh from announcing that the company will acquire Foresight BioTherapeutics for $300m (here), Shire stepped up its ambitions to acquire the recently spun-out Baxalta, which went public earlier this...
View ArticleCortendo joins a rare disease crowd in Ireland
Sweden’s Cortendo AB has announced its intention to relocate the parent company of the Cortendo group from Sweden to Ireland. The Company is contemplating effecting such redomiciliation through an...
View ArticleDavid Epstein emerges at newly named Flagship Pioneering
Flagship Pioneering today announced the appointment of industry veteran David Epstein to serve in the newly created role of Executive Partner. Epstein will join as a strategic resource to the firm that...
View Article
